Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

janssen pharmaceuticals inc. - esketamine hydrochloride (unii: l8p1h35p2z) (esketamine - unii:50lfg02txd) - spravato ® is indicated, in conjunction with an oral antidepressant, for the treatment of: - treatment-resistant depression (trd) in adults - depressive symptoms in adults with major depressive disorder (mdd) with acute suicidal ideation or behavior limitations of use: - the effectiveness of spravato in preventing suicide or in reducing suicidal ideation or behavior has not been demonstrated [see clinical studies (14.2)] . use of spravato does not preclude the need for hospitalization if clinically warranted, even if patients experience improvement after an initial dose of spravato. - spravato is not approved as an anesthetic agent. the safety and effectiveness of spravato as an anesthetic agent have not been established. spravato is contraindicated in patients with: - aneurysmal vascular disease (including thoracic and abdominal aorta, intracranial, and peripheral arterial vessels) or arteriovenous malformation [see warnings and precautions (5.7)] - history of intracere

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - ketamine hydrochloride, quantity: 115.3 mg/ml (equivalent: ketamine, qty 100 mg/ml) - injection, solution - excipient ingredients: water for injections; benzethonium chloride - ketalar is recommended: 1. as the sole anaesthetic agent for diagnostic and surgical procedures that do not require skeletal muscle relaxation. ketalar is best suited for short procedures and it can be used with additional doses, for longer procedures; 2. for the induction of anaesthesia prior to the administration of other general anaesthetic agents, and 3. to supplement low-potency agents, such as nitrous oxide.

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

henry schein animal health - ketamine hydrochloride (unii: o18yuo0i83) (ketamine - unii:690g0d6v8h) - ketathesia™ (ketamine hydrochloride injection, usp) may be used in cats for restraint or as the sole anesthetic agent for diagnostic or minor, brief, surgical procedures that do not require skeletal muscle relaxation. it may be used in subhuman primates for restraint. ketamine hydrochloride is contraindicated in cats and subhuman primates suffering from renal or hepatic insufficiency. ketamine hydrochloride is detoxified by the liver and excreted by the kidneys; therefore, any preexistent hepatic or renal pathology or impairment of function can be expected to result in prolonged anesthesia; related fatalities have been reported.

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

clipper distributing company, llc - ketamine hydrochloride (unii: o18yuo0i83) (ketamine - unii:690g0d6v8h) - ketamine 100 mg in 1 ml

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

vedco inc. - ketamine hydrochloride (unii: o18yuo0i83) (ketamine - unii:690g0d6v8h) - ketamine 100 mg in 1 ml

Кенија - Енглески - Pharmacy and Poisons Board

rotexmedica gmbh arzneimittelwerk bunsenstrasse 4, 22946 trittau, germany - ketamine hydrochloride - solution for injection - 1 vial of 10 ml contains 577 mg ketamine… - other general anesthetics

Велика Британија - Енглески - MHRA (Medicines & Healthcare Products Regulatory Agency)

panpharma uk ltd - ketamine hydrochloride - solution for injection - 50mg/1ml

Нови Зеланд - Енглески - Ministry for Primary Industries

ceva animal health (nz) limited - ketamine hydrochloride - ketamine hydrochloride 115.6 g/litre - anaesthetic

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

general injectables & vaccines, inc - ketamine hydrochloride (unii: o18yuo0i83) (ketamine - unii:690g0d6v8h) - ketalar (ketamine hydrochloride) injection is indicated: - as the sole anesthetic agent for diagnostic and surgical procedures that do not require skeletal muscle relaxation. - for the induction of anesthesia prior to the administration of other general anesthetic agents. - as a supplement to other anesthetic agents. - ketalar is contraindicated in patients for whom a significant elevation of blood pressure would constitute a serious hazard [see warnings and precautions(5.1)]. - ketalar is contraindicated in patients with known hypersensitivity to ketamine or to any excipient [see adverse reactions(6)]. 8.1 pregnancy risk summary there are no adequate and well-controlled studies of ketalar in pregnant women. in animal reproduction studies in rats developmental delays (hypoplasia of skeletal tissues) were noted at 0.3 times the human intramuscular dose of 10 mg/kg. in rabbits, developmental delays and increased fetal resorptions were noted at 0.6 times the human dose. published studies in pregnant primates d

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

henry schein, inc - ketamine hydrochloride (unii: o18yuo0i83) (ketamine - unii:690g0d6v8h) - ketalar (ketamine hydrochloride) injection is indicated: - as the sole anesthetic agent for diagnostic and surgical procedures that do not require skeletal muscle relaxation. - for the induction of anesthesia prior to the administration of other general anesthetic agents. - as a supplement to other anesthetic agents. - ketalar is contraindicated in patients for whom a significant elevation of blood pressure would constitute a serious hazard [see warnings and precautions(5.1)]. - ketalar is contraindicated in patients with known hypersensitivity to ketamine or to any excipient [see adverse reactions(6)]. 8.1 pregnancy risk summary there are no adequate and well-controlled studies of ketalar in pregnant women. in animal reproduction studies in rats developmental delays (hypoplasia of skeletal tissues) were noted at 0.3 times the human intramuscular dose of 10 mg/kg. in rabbits, developmental delays and increased fetal resorptions were noted at 0.6 times the human dose. published studies in pregnant primates d